| |
« Back to main page
Sort list by presenter
· by title
· by ID number
· search by keyword
Click abstract title for more information
The poster  icon indicates a Virtual Poster can be viewed online
Displaying all abstracts in category:
Lymphoma
|
|
|
2317: Radiotherapy as Primary Treatment for Localized Stage IE and IIE Nasal NK/T Cell Lymphoma
|
Li, Yexiong |
|
2318: The Safety and Efficacy of Standard-Dose 90Y Ibritumomab Tiuxetan Combined with High-Dose BEAM and AutologousStem-Cell Transplantation in Patients, Including Those Over 60 Years, with Non-Hodgkin's Lymphoma
|
Krishnan, Amrita |
|
2319: Low Dose Total Body Irradiation Prior to Allograft for Heamtologic Malignancies: a Retrospective Review from the Acute Leukemia Working Party of the European Blood and Marrow Transplantation
|
Belkacemi, Yazid |
|
2320: Radioimmunotherapy with Yttrium 90 Ibritumomab Tiuxetan (Zevalin
|
Meredith, Ruby |
|
2321: Highly Effective Local Control and Palliation of Mantle Cell Lymphoma (MCL) with Involved-Field Radiation Therapy (IFRT)
|
Rosenbluth, Benjamin |
|
2322: Value of PET Restaging after Chemotherapy for Non-Hodgkins Lymphoma: Implications for Consolidation Radiotherapy
|
Kahn, Shannon |
|
2323: A Dosimetric Study of Mantle versus Involved-Field Radiotherapy for Hodgkin's Lymphoma: Implications for Second Cancer Risk and Cardiac Toxicity
|
Koh, Eng-Siew |
|
2324: Predictors of Response and Differential Mechanisms of Action for Anti-CD20 Radio-Immunotherapy
|
Macklis, Roger |
|
2325: Is Intensity-Modulated Radiotherapy Better than Conventional Radiation Treatment and 3D Conformal Radiotherapy for Mediastinal Masses in Patients with Hodgkin's Disease? Is there a Role for Beam Orientation Optimization and Dose Constraints Assigned to Virtual Volumes?
|
Ghalibafian, Mithra |
|
2326: A Prospective Study to Evaluate the Need for an Immobilization Device for Treating Modified Mantle Fields in Lymphoma Patients
|
Billingsley, Susan |
|
2327: Clinical Significance of Cyclooxygenase-2 in NK/T-Cell Lymphoma, Nasal Type
|
Shim, Su Jung |
|
2328: The Impact of Involved Field Radiation Therapy for Patients Receiving High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
|
Wendland, Merideth |
|
2329: Extranodal Natural killer/T-cell Lymphoma of Nasal Type: The Toronto Experience
|
Tsang, Richard |
|
2330: Impact of Full Dose of Rituximab on Pharmacokinetics and Dosimetry of Zevalin for Patients with Non-Hodgkin's Lymphoma
|
Shen, S |
|
2331: Preliminary Results of a Prospective Study of Dose Reduced Short-Course CHOP followed by Involved Field Radiotherapyfor Elder Patients 70 Years Old or More with Localized Aggressive non-Hodgkins Lymphomas (Japan Radiation Oncology Group; JAROG Study)
|
Shikama, Naoto |
|
2332: Pre-Stem Cell Transplant Pulmonary Function Tests (PFTs) Predict Risk of Mortality in the Absence of Pulmonary Lung Shielding with Fractionated Total Body Irradiation (TBI)
|
Mansueti, John |
|
|
